365 Results
Regimen
Guidelines and Advice
Status: Current
ID: GL 8-10
Version: N/A
ID: GL 8-10
Version: N/A
Dec 1969
Regimen
Regimen
Statistical Reports
Cette page s’adresse aux personnes ayant récemment reçu un diagnostic de leucémie aiguë lymphoblastique (LAL)
This page is for drug manufacturers who need information on the cancer drug submission process.
Please do not mail cancer drug submissions to Ontario...
Document
Document